Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.51
-0.08-1.05%
Last update: Dec 15, 11:33 AM
Comments
Loading...
Nuvectis Pharma (NVCT) Stock Price, Quote, News & History
NVCTNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nuvectis Pharma (NVCT) stock?
You can purchase shares of Nuvectis Pharma (NASDAQ:NVCT) through any online brokerage.
Who are Nuvectis Pharma (NVCT) competitors?
Other companies in Nuvectis Pharma’s space includes: Kalaris Therapeutics Inc (NASDAQ:KLRS), Cabaletta Bio Inc (NASDAQ:CABA), Innate Pharma SA (NASDAQ:IPHA), Armata Pharmaceuticals Inc (AMEX:ARMP) and Vistagen Therapeutics Inc (NASDAQ:VTGN).
What is the forecast, or price target, for Nuvectis Pharma (NVCT) stock?
Nuvectis Pharma has a consensus price target of $15.33.
What is the current price for Nuvectis Pharma (NVCT)?
The stock price for Nuvectis Pharma (NASDAQ: NVCT) is $7.51 last updated December 15, 2025 at 11:33 AM EST.
Does Nuvectis Pharma (NVCT) pay a dividend?
There are no upcoming dividends for Nuvectis Pharma.
When is Nuvectis Pharma (NASDAQ:NVCT) reporting earnings?
Nuvectis Pharma does not have any upcoming earnings scheduled.
Is Nuvectis Pharma (NVCT) going to split?
There is no upcoming split for Nuvectis Pharma.
What sector and industry does Nuvectis Pharma (NVCT) operate in?
Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
